12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Clonidine hydrochloride extended-release is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [ see Clinical Studies (14) ]. Clonidine hydrochloride extended-release tablets are a centrally acting alpha 2 -adrenergic agonist indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications. ( 1 )

American Health Packaging

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] pain` `[3] fatigue` `[4] nausea` `[5] headache` `[6] arthralgia` `[7] dyspnoea` `[8] vomiting` `[9] diarrhoea` `[10] rash`

3 years ago

ROUND WHITE CL

16 HOW SUPPLIED/STORAGE AND HANDLING

CLONIDINE HYDROCHLORIDE extended-release tablets, USP are white to off-white, circular biconvex debossed with ("CL”) on one side and plain on other side. The 0.1 mg round tablets are supplied as unit dose packages of 30 (3 x 10) NDC 60687-462-21 Store at 20° to 25°C (68°-77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken.

More pills like ROUND CL

Related Pills

Guaifenesin 400 MG Oral Tablet

Sunrise Pharmaceutical Inc

Meclizine Hydrochloride 25 MG Oral Tablet

Unifirst First Aid Corporation

Chlorpheniramine Maleate 4 MG Oral Tablet

Unifirst First Aid Corporation

Claritin 10 MG Oral Tablet

MSD Consumer Care, Inc.

Pramipexole dihydrochloride Pramipexole dihydrochloride 0.25 MG Oral Tablet

Macleods Pharmaceuticals Limited

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site